Gastroenterology, Hepatology and Nutrition Service, Paediatric Medicine, KK Women's and Children's Hospital, Singapore.
Division of Paediatric Gastroenterology, Nutrition, Hepatology and Liver Transplantation, Department of Paediatrics, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.
Singapore Med J. 2022 Nov;63(11):659-666. doi: 10.11622/smedj.2021138. Epub 2021 Oct 4.
The aetiology of paediatric acute liver failure (PALF) varies widely according to age, and geographic and socioeconomic factors. This study aimed to examine the epidemiology, aetiology and outcome of PALF in Singapore at a single centre.
A retrospective review was performed of patients aged 0-18 years who were diagnosed with PALF from 2007 to 2019. PALF was defined by: absence of chronic liver disease; biochemical evidence of acute liver injury; and coagulopathy, non-correctible by vitamin K, defined as prothrombin time (PT) ≥20 seconds or international normalised ratio (INR) ≥2.0 regardless of hepatic encephalopathy (HE) or PT ≥15 seconds or INR ≥1.5 in the presence of HE.
34 patients were included. Median age at diagnosis was 10 months (range 7 days to 156 months). The top three causes of PALF were indeterminate (41.2%), metabolic (26.5%) and infectious (26.5%) aetiologies. A metabolic disorder was the most frequent aetiology in infants <12 months (38.9%), whereas an indeterminate cause was the most common in children >12 months (50%). No cases of viral hepatitis A or B presenting with PALF were detected. Overall spontaneous recovery rate (survival without liver transplantation [LT]) was 38.2%, and overall mortality rate was 47.1%. Six patients underwent living-donor LT, and the post-transplant survival at one year was 83.3%.
The aetiologic spectrum of PALF in Singapore is similar to that in developed Western countries, with indeterminate aetiology accounting for the majority. PALF is associated with poor overall survival; hence, timely LT for suitable candidates is critical to improve survival outcomes.
小儿急性肝衰竭(PALF)的病因因年龄、地理和社会经济因素而有很大差异。本研究旨在研究单一中心新加坡 PALF 的流行病学、病因和结局。
对 2007 年至 2019 年间诊断为 PALF 的 0-18 岁患者进行回顾性分析。PALF 的定义为:无慢性肝病;生化证据表明存在急性肝损伤;凝血功能障碍,无法用维生素 K 纠正,定义为凝血酶原时间(PT)≥20 秒或国际标准化比值(INR)≥2.0,无论是否存在肝性脑病(HE)或 PT≥15 秒或 INR≥1.5 伴 HE。
共纳入 34 例患者。中位诊断年龄为 10 个月(范围 7 天至 156 个月)。PALF 的前三大病因是未明(41.2%)、代谢(26.5%)和感染(26.5%)。代谢紊乱是<12 个月婴儿最常见的病因(38.9%),而>12 个月儿童最常见的病因是未明原因(50%)。未发现甲型或乙型病毒性肝炎引起的 PALF。总体自发恢复率(无肝移植[LT]生存)为 38.2%,总死亡率为 47.1%。6 例患者接受活体供者 LT,术后 1 年存活率为 83.3%。
新加坡 PALF 的病因谱与发达国家相似,以未明原因为主。PALF 总体生存率较差;因此,及时为合适的候选者进行 LT 对于改善生存结局至关重要。